Featured Cover

Ün, İlker; Ün, Şule Şahin; Tanrıkulu, Nazim; Ünlü, Aişe; Ok, Salim

doi:10.1002/pca.3125

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…NMR samples were prepared by dissolving samples in D 2 O. Measurements were conducted using Varian VNMRs 600 spectrometer operating at 400 MHz for 1 H resonance frequency and 5 mm NMR sample tubes. [ 42 ] Data acquisition and processing were conducted using Vnmrj 4.2 software and Bruker TopSpin 4.1.4 software, respectively.…”

Section: Methodsmentioning

confidence: 99%

Hyaluronan‐Sphingosine Polymersomes for Treatment of Ocular Neovascularization: Synthesis and Evaluation

Yetisgin,

Durak,

Kutlu

et al. 2024

Macromolecular Bioscience

View full text Add to dashboard Cite

Ocular neovascularization is a hallmark of several sight‐threatening diseases, including diabetic retinopathy and age‐related macular degeneration. Currently, available treatments are limited and often associated with side effects. Therefore, we present a novel approach to ocular neovascularization treatment through utilization of polymersomes from self‐assembled sphingosine‐grafted hyaluronic acid (HA‐Sph) amphiphilic polymers. The polymersomes are generated in spherical morphologies and sizes between 97.95 nm – 161.9 nm with homogenous size distributions. Our experiments revealed that HA‐Sph polymersomes, with concentrations ≥150 μg/mL, significantly inhibit the proliferation of HUVECs, while concurrently promoting the proliferation of retinal pigment epithelial cells. The polymersomes demonstrated gradual disintegration in vitro, leading to a sustained release of sphingosine, which prolonged the inhibition of HUVEC proliferation (from 87.5% at 24 h to 35.2% viability at 96 h). The efficacy of HA‐Sph polymersomes in inhibiting angiogenesis was confirmed through tube formation assay, revealing a substantial reduction in total tube length compared to the control group. Our findings also validated the ocular penetration capability of polymersomes through an ex vivo whole porcine eye ocular penetration study, indicating their suitability for topical administration. Potentially, HA‐Sph polymersomes can be harnessed to develop intricate drug delivery systems that protect the retina and effectively treat ocular diseases.This article is protected by copyright. All rights reserved

show abstract

Section: Methodsmentioning

confidence: 99%